Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

AbbVie doubles down on immunology with US$ 2.1 bn Capstan buyout; India's Torrent buys controlling stake in JB Chem

This week in Phispers, AbbVie struck a deal worth up to US$ 2.1 billion to acquire Capstan Therapeutics and its innovative in v...

Impressions : 469

Royalty Pharma inks US$ 2 bn cancer drug deal with Revolution; Astra-Daiichi's Datroway wins US approval for lung cancer

In news this week, Royalty Pharma committed up to US$ 2 billion to Revolution Medicines for their promising pancreatic and lung...

Impressions : 2833

Lilly acquires gene-editing firm Verve for US$ 1.3 bn, BioNTech buys CureVac; Astra signs US$ 5.3 bn AI deal with China's CSPC

This week’s Phispers comes with news on several M&A deals. Eli Lilly made headlines with its US$ 1.3 billion acquisition ...

Impressions : 559

RFK Jr fires all 17 members of CDC's vaccine committee; Merck's oral cholesterol drug meets goals in late-stage trials

This week, US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. dismissed all 17 members of the US Centers for D...

Impressions : 1043

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

AbbVie doubles down on immunology with US$ 2.1 bn Capstan buyout; India's Torrent buys controlling stake in JB Chem

Royalty Pharma inks US$ 2 bn cancer drug deal with Revolution; Astra-Daiichi's Datroway wins US approval for lung cancer

Lilly acquires gene-editing firm Verve for US$ 1.3 bn, BioNTech buys CureVac; Astra signs US$ 5.3 bn AI deal with China's CSPC

RFK Jr fires all 17 members of CDC's vaccine committee; Merck's oral cholesterol drug meets goals in late-stage trials

Regeneron's Biologics Lynozyfic Receive Approval in US

Eli Lilly's Biologics Kisunla Receive Suppl Approval in US

BMS's Biologics Opdivo Receive Suppl Approval in US

Annora Pharma's Generics Prucalopride Receives Approval in US

Aggrega's Generics Prucalopride Receives Approval in US

H2-Pharma's Generics Prucalopride Receives Approval in US

Unique's Generics Alcohol Receives Approval in US

Unique's Generics Amitriptyline HCl Receives Approval in US

Torrent's Generics Apremilast Receives Approval in US

GSK's Biologics Benlysta Receives Suppl Approval in US

Enforcement Report - Week of July 2, 2025

Staska Pharmaceuticals Recieves Warning Letter

Sandoz Issues a Nationwide Recall of Cefazolin

Enforcement Report - Week of June 25, 2025

Zhejiang Medicinel is on Health Canada Inspection List

Yiling Pharmaceutical is on Health Canada Inspection List

Emix Limited's Fails EDQM inspection

Enforcement Report - Week of June 18, 2025

Huahai Pharma Recieves Warning Letter

Kenil Healthcare Recieves Warning Letter

MIRA's Mira-55 Matches Morphine in Animal Model for Inflammatory

J&J seeks EMA approval to expand Akeega

Alembic Pharma Acquires Utility Therapeutics for $12 Million

Novartis Drug Cosentyx Fails Late-Stage Trial for Artery Disease

Summit, Astrazeneca in Talks Over 15 B Cancer Drug Licensing Deal

RFK Jr. Eyes Changes to Vaccine Injury Compensation Program

US FDA Approves Regeneron's Blood Cancer Therapy

Delhi Hc Seeks Regulator's Reply on Ozempic, Mounjaro Nod in Pil

India's Exports to Brazil Show Trust in Pharma Capabilities

Lupin Gets FDA nod for Loteprednol Etabonate Ophthalmic Gel

Lupin Gets FDA nod for Loteprednol Etabonate Ophthalmic Gel

FDA Confirms Para IV Patent Litigation for Veklury Powder for Inj

Asahi Kasei Pharma Begins Phase III Study on Cipn Prevention

Cadila Pharmaceuticals launches Bilacad Dex Syrup

Pharmexcil Talks with US on Trade Facilitation, Market Access

Alembic Gets US FDA Approval for Doxorubicin Liposome

Alembic Announces USFDA Final Approval for Single-Dose Vials

India's Biocon Drops Plan to Launch Weight-Loss Drugs in China

Lupin Launches Prucalopride Tablets in U.S.

Lupin receives USFDA approval for Prucalopride Tablets

Novartis Drug Cosentyx Fails Late-Stage Trial for Artery Disease

RFK Jr. Eyes Changes to Vaccine Injury Compensation Program

US FDA Approves Regeneron's Blood Cancer Therapy

Delhi Hc Seeks Regulator's Reply on Ozempic, Mounjaro Nod in Pil

Biokin, having landed BMS deal, posts ph. 3 Bispecific ADC win

Sandoz Pumps $440 M Into Another Slovenia Biosimilar Plant

AstraZeneca Pharma India Approved for Endometrial Cancer

Lyme IgM and IgG ImmunoBlots Receive FDA Clearance

Tonix Pharmaceuticals Announces Publication in Journal

Shattuck Labs to Join Leerink Partners Therapeutics Forum

BDMA to review Sigachi Pharma explosion in Hyderabad: RK Agarwal

Axcelead, A2 Healthcare Partner to Accelerate Drug R&D

Nippon Shokubai to Expand Nucleic Acid API Capacity 10x

DBT to Support Biomanufacturing of APIs to reduce GHG emissions

Sigachi Gets ToR Approval For API & Chemicals Manufacturing

Zydus gets EIR for API facility at Ankleshwar & Dabhasa

India Must Enhance Role as Global Supply Chain Innovator

Lubrizol's Apisolex Polymer Excipient in Phase I Candidate

Carbogen Amcis to Co-Invest CHF 25M+ in Swiss Expansion

Lubrizol Announces Milestone for Apisolex™ Polymer

Govt to Bring in Barcodes to Fight Fake Drug Menace

Plans to Restrict Open Market Access to Tuberculosis Medicines

Aurobindo Pharma recalls 4,608 pain reliever bottles in US

CDC Panel Recommends Against Use of Thimerosal in Flu Vaccines

Pondicherry Pharma MSMEs Face Deadline in CDSCO's cGmp Crackdown

FDA Warns Sterling Distributors for DSCSA Compliance Issues

Glenmark's Facility Gets 5 FDA Observations Post-Inspection

Gland Pharma Gets USFDA EIR for Visakhapatnam Facility

Concord Biotech's API facility completes USFDA inspection

Fixing Extractables & Leachables Studies for Regulatory Review

Covid-19 jabs don't raise risk of sudden death: ICMR-NIE Director

Glen Ventures Invests in Sensifai Health for Preemptive Health

The Ensign Group Continues Growth in Idaho